{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.11.1157-20240302",
  "meta": {
    "versionId": "21",
    "lastUpdated": "2024-03-02T01:18:41.000-05:00",
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueContactDetail": {
      "name": "NCQA PHEMUR Author"
    }
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2025-03-10"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2024-03-02"
  } ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1157",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "urn:oid:2.16.840.1.113883.3.464.1003.110.11.1157"
  } ],
  "version": "20240302",
  "name": "HiBVaccine4DoseScheduleAdministered",
  "title": "HiB Vaccine (4 dose schedule) Administered",
  "status": "active",
  "date": "2024-03-02T01:18:41-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [ {
    "extension": [ {
      "url": "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueCode": "unknown"
    } ]
  } ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for a 4-dose haemophilus influenzae type b (Hib) vaccines.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for a 4-dose haemophilus influenzae type b (Hib) vaccination.),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [ {
      "system": "http://snomed.info/sct",
      "concept": [ {
        "code": "310306005",
        "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      }, {
        "code": "310307001",
        "display": "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      }, {
        "code": "310308006",
        "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      }, {
        "code": "312870000",
        "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
      }, {
        "code": "414001002",
        "display": "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      }, {
        "code": "414259000",
        "display": "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      }, {
        "code": "415507003",
        "display": "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      }, {
        "code": "415712004",
        "display": "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
      } ]
    } ]
  },
  "expansion": {
    "identifier": "urn:uuid:f4ff515d-b03d-4fbc-b147-ae0e4b78a077",
    "timestamp": "2025-06-20T16:52:36-04:00",
    "total": 8,
    "offset": 0,
    "parameter": [ {
      "name": "count",
      "valueInteger": 1000
    }, {
      "name": "offset",
      "valueInteger": 0
    } ],
    "contains": [ {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "310306005",
      "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "310307001",
      "display": "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "310308006",
      "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "312870000",
      "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "414001002",
      "display": "Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "414259000",
      "display": "Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "415507003",
      "display": "Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20230901",
      "code": "415712004",
      "display": "Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure)"
    } ]
  }
}